Correlation Between AusCann Group and Aion Therapeutic

Can any of the company-specific risk be diversified away by investing in both AusCann Group and Aion Therapeutic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AusCann Group and Aion Therapeutic into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between AusCann Group Holdings and Aion Therapeutic, you can compare the effects of market volatilities on AusCann Group and Aion Therapeutic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AusCann Group with a short position of Aion Therapeutic. Check out your portfolio center. Please also check ongoing floating volatility patterns of AusCann Group and Aion Therapeutic.

Diversification Opportunities for AusCann Group and Aion Therapeutic

0.09

Correlation Coefficient

AusCann Group  Aion Therapeutic

Significant diversification

The 3 months correlation between AusCann and Aion is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding AusCann Group Holdings and Aion Therapeutic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aion Therapeutic and AusCann Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AusCann Group Holdings are associated (or correlated) with Aion Therapeutic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aion Therapeutic has no effect on the direction of AusCann Group i.e., AusCann Group and Aion Therapeutic go up and down completely randomly.

Pair Corralation between AusCann Group and Aion Therapeutic

Assuming the 90 days horizon AusCann Group Holdings is expected to generate 2.33 times more return on investment than Aion Therapeutic. However, AusCann Group is 2.33 times more volatile than Aion Therapeutic. It trades about 0.16 of its potential returns per unit of risk. Aion Therapeutic is currently generating about 0.11 per unit of risk. If you would invest  0.30  in AusCann Group Holdings on September 14, 2024 and sell it today you would earn a total of  0.08  from holding AusCann Group Holdings or generate 26.67% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	86.46%
Values	Daily Returns

AusCann Group Holdings  vs.  Aion Therapeutic

AusCann Group Holdings

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days AusCann Group Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, AusCann Group is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Aion Therapeutic

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Aion Therapeutic are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile fundamental indicators, Aion Therapeutic reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with AusCann Group and Aion Therapeutic

The main advantage of trading using opposite AusCann Group and Aion Therapeutic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AusCann Group position performs unexpectedly, Aion Therapeutic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aion Therapeutic will offset losses from the drop in Aion Therapeutic's long position.

The idea behind AusCann Group Holdings and Aion Therapeutic pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.